Vaxcyte Inc. (PCVX)
NASDAQ: PCVX
· Real-Time Price · USD
32.66
1.23 (3.91%)
At close: Aug 15, 2025, 3:59 PM
32.70
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT
Vaxcyte Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 14.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 4.99M | n/a | n/a | 4.5M | 3.48M | 3.09M | 2.95M | 2.48M | 2.4M | 2.34M | 2.3M | 2.35M | 2.16M | 2.37M | 1.21M | 846K | 868K | 527K |
Gross Profit | -4.99M | n/a | n/a | -4.5M | -3.48M | -3.09M | 11.5M | -2.48M | -2.4M | -2.34M | -2.3M | -2.35M | -2.16M | -2.37M | -1.21M | -846K | -868K | -527K |
Operating Income | -226.22M | -180.79M | -162.17M | -139.92M | -152.98M | -114.47M | -121.68M | -113.03M | -87.15M | -71.19M | -86.57M | -58.58M | -47.89M | -39.22M | -29.85M | -26.95M | -23.73M | -23.14M |
Interest Income | 31.07M | 32.94M | 36.46M | 28.06M | 23.81M | 21.67M | 17.57M | 18.5M | 16.45M | 10.39M | 6.63M | 1.19M | 399K | 134K | 99K | 90K | 93K | 61K |
Pretax Income | -166.57M | -140.72M | -137.08M | -103.12M | -128.7M | -95.02M | -180.8M | -92.66M | -68.34M | -60.46M | -78.05M | -57.92M | -48.53M | -38.99M | -28.56M | -26.61M | -23.68M | -21.22M |
Net Income | -166.57M | -140.72M | -137.08M | -103.12M | -128.7M | -95.02M | -180.8M | -92.66M | -68.34M | -48.36M | -93.45M | -57.26M | -49.18M | -38.75M | -28.56M | -26.61M | -23.68M | -21.22M |
Selling & General & Admin | 27.05M | 32.66M | 28.55M | 22.99M | 18M | 19.89M | 14.58M | 15.61M | 14.46M | 13.11M | 11.95M | 10.9M | 9.42M | 7.54M | 6.77M | 6.52M | 6.08M | 5.88M |
Research & Development | 194.18M | 148.13M | 133.61M | 116.94M | 131.51M | 94.59M | 104.15M | 97.42M | 72.69M | 58.08M | 51.63M | 47.68M | 38.47M | 31.68M | 23.07M | 20.43M | 17.65M | 17.26M |
Other Expenses | n/a | n/a | n/a | n/a | -394K | n/a | n/a | n/a | n/a | -654K | -925K | -157K | -690K | -160K | -908K | -299K | -378K | n/a |
Operating Expenses | 221.23M | 180.79M | 162.17M | 139.92M | 149.5M | 114.35M | 118.73M | 113.03M | 84.68M | 70.54M | 62.65M | 58.42M | 47.2M | 39.06M | 28.94M | 26.65M | 23.35M | 23.14M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | n/a | n/a | n/a | 7K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -3.48M | n/a | -2.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 226.22M | 180.79M | 162.17M | 139.92M | 152.98M | 114.35M | 121.68M | 113.03M | 84.68M | 70.54M | 62.65M | 58.42M | 47.2M | 39.06M | 28.94M | 26.65M | 23.35M | 23.14M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 14.58M | n/a | n/a | -12.1M | 15.4M | -660K | 646K | -235K | n/a | 10K | 7K | n/a |
Shares Outstanding (Basic) | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 102.53M | 101.67M | 98.06M | 86.21M | 79.01M | 61.99M | 60.82M | 57.33M | 52.81M | 52.19M | 51.48M | 51.17M |
Shares Outstanding (Diluted) | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 102.53M | 101.67M | 98.06M | 86.21M | 79.01M | 61.99M | 60.82M | 57.55M | 52.81M | 52.19M | 51.51M | 51.17M |
EPS (Basic) | -1.22 | -1.04 | -1.12 | -0.83 | -1.1 | -0.85 | -1.76 | -0.91 | -0.7 | -0.56 | -1.18 | -0.92 | -0.81 | -0.68 | -0.54 | -0.51 | -0.46 | -0.41 |
EPS (Diluted) | -1.22 | -1.04 | -1.12 | -0.83 | -1.1 | -0.85 | -1.76 | -0.91 | -0.7 | -0.56 | -1.18 | -0.92 | -0.81 | -0.67 | -0.54 | -0.51 | -0.46 | -0.41 |
EBITDA | -161.58M | -175.92M | -52.58M | -139.92M | -152.98M | -113.47M | -177.85M | -90.18M | -87.15M | -70.48M | -75.71M | -55.56M | -47.89M | -36.62M | -27.36M | -25.77M | -22.81M | -22.62M |
EBIT | -166.57M | -180.79M | -57.36M | -139.63M | -152.59M | -114.35M | -180.8M | -92.66M | -84.68M | -70.54M | -78.05M | -57.92M | -48.53M | -39.06M | -28.56M | -26.61M | -23.68M | -23.14M |
Depreciation & Amortization | 4.99M | 4.87M | 4.79M | n/a | 3.48M | 3.09M | 2.95M | 2.48M | 2.4M | 2.34M | 2.3M | 2.35M | 2.16M | 2.37M | 1.21M | 846K | 868K | 527K |